Real-world Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study

Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland

(2019) Jarmo Oksi et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence

(2018) Dale N Gerding et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

(2018) L Clifford McDonald et al.   CLINICAL INFECTIOUS DISEASES

Bezlotoxumab

(2018) Stuart Johnson et al.   CLINICAL INFECTIOUS DISEASES

Efficacy of bezlotoxumab based on timing of administration relative to start of antibacterial therapy for Clostridium difficile infection

(2018) Thomas Birch et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clostridioides (formerly Clostridium) difficile infection during hospitalization increases the likelihood of non-home patient discharge

(2018) Kelly R Reveles et al.   CLINICAL INFECTIOUS DISEASES

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

(2017) Mark H. Wilcox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection

(2017) Raseen Tariq et al.   JAMA Internal Medicine

Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach

(2016) Kamal Desai et al.   BMC INFECTIOUS DISEASES

Clinical and Healthcare Burden of Multiple Recurrences ofClostridium difficileInfection

(2015) Caroline Sheitoyan-Pesant et al.   CLINICAL INFECTIOUS DISEASES

Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes ofClostridium difficileinfection: a systematic review and meta-analysis

(2015) C. Thongprayoon et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Risk Factors for Recurrence, Complications and Mortality in Clostridium difficile Infection: A Systematic Review

(2014) Claire Nour Abou Chakra et al.   PLoS One

Comparison of 3 Severity Criteria for Clostridium difficile Infection

(2013) Angela Gomez-Simmonds et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Clostridium difficile infection: management strategies for a difficult disease

(2013) Sahil Khanna et al.   Therapeutic Advances in Gastroenterology

Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin

(2012) O. A. Cornely et al.   CLINICAL INFECTIOUS DISEASES

Burden of Clostridium difficile on the Healthcare System

(2012) Erik R. Dubberke et al.   CLINICAL INFECTIOUS DISEASES

Can we identify patients at high risk of recurrent Clostridium difficile infection?

(2012) C.P. Kelly   CLINICAL MICROBIOLOGY AND INFECTION

Treatment with Monoclonal Antibodies againstClostridium difficileToxins

(2010) Israel Lowy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Meta-analysis to assess risk factors for recurrent Clostridium difficile infection

(2008) K.W. Garey et al.   JOURNAL OF HOSPITAL INFECTION